Skip to main content

Engineering biology

Inquiry

The House of Lords Science and Technology Committee is conducting an inquiry into engineering biology. The committee will explore engineering biology’s potential, particularly in delivering UK economic growth through commercialisation and for improvements to public services; which areas of engineering biology the UK is well placed to exploit and where additional support may be needed; and the ethical, regulatory and safety implications of rapid developments in the field. The committee has issued a call for written evidence and will be taking oral evidence from April 2024.

This inquiry is no longer accepting evidence

The deadline for submissions was Tuesday 7 May 2024.

Reports, special reports and government responses

No reports or special reports published.

Oral evidence transcripts

View all oral evidence transcripts
7 May 2024
Inquiry Engineering biology
Witnesses National Physical Laboratory, Food Standards Agency, and UK Health Security Agency (UKHSA)
Oral Evidence
21 May 2024
Inquiry Engineering biology
Witnesses Fiona Mischel (Director of International Outreach at SynBioBeta), Dr Mary Maxon (Executive Director at BioFutures, Schmidt Sciences), and Dr Hendrik Waegeman (Head of Business Operations at Bio Base Europe Pilot Plant)
Oral Evidence
21 May 2024
Inquiry Engineering biology
Witnesses INEOS, LanzaTech UK, and Charles Hall (Head of Research at Peel Hunt)
Oral Evidence
Dr Sara Holland (Patent Attorney at Potter Clarkson) (ENB0055)
Constructive Bio (ENB0054)
UK Research and Innovation (UKRI) (ENB0053)

Other publications

No other publications published.

Contact us

  • Email: hlscience@parliament.uk
  • Phone: 020 7219 5750 (committee staff) | 020 7219 1692 (Press Officer)
  • Address: Science and Technology Committee, House of Lords, London SW1A 0PW